注：业绩比较基准不是预期收益率，不代表产品的未来表现和实际收益，不构成对产品收益的承诺。 2月4日，据贝莱德建信理财披露，该公司发行的贝远稳航美元固定收益类理财产品第22期（封闭式）募 集期为2026年2月4日至2026年2月10日。认购金额1美元起，产品规模上限不超过3000万美元，产品规模 下限不低于100万美元。产品类型为固定收益类，产品内部风险评级为R1低风险，产品期限350天，业 绩比较基准（年化）3.10%。 以上理财产品信息仅供参考，具体应以《产品说明书》等销售文件为准。本文不构成任何投资建议，投 资者据此操作，风险自担。 ...

2月4日，据招银理财披露，该公司发行的招睿和鼎美元封闭230号固收类理财计划认购期为2026年2月4 日到2026年2月9日。GS份额认购起点为2000美元，发行规模上限1000万美元。产品类型为固定收益 类，风险收益评级为PR1低风险，理财计划预计存续期为181天，GS份额业绩比较基准为3.15%-3.65% （年化）。 注：业绩比较基准不是预期收益率，不代表产品的未来表现和实际收益，不构成对产品收益的承诺。 以上理财产品信息仅供参考，具体应以《产品说明书》等销售文件为准。本文不构成任何投资建议，投 资者据此操作，风险自担。 ...

邵根伙逝世后，公司现任董事人数由9人减少至8人，不会导致公司董事会成员低于法定最低人数。根据 《公司章程》的规定，由公司副董事长张立忠代行董事长职责，直至公司董事会选举新任董事长为止。 目前，公司董事会、高级管理人员正常履职，公司各项经营业务正常开展。 （企业公告） 2月4日，大北农发布公告称，公司实际控制人、董事长邵根伙于2026年2月3日因病逝世，享年60 岁。 ...

Core Viewpoint - The Beijing Municipal Transportation Committee has released the "2026 Beijing Comprehensive Transportation Governance Action Plan," focusing on promoting low-carbon transportation and enhancing the infrastructure for electric vehicles and bicycles [1] Group 1: Low-Carbon Transition - The plan emphasizes the continuous promotion of electric vehicles in public sectors such as tourism charter services, road freight, public buses, and ride-hailing services [1] - It aims to increase the coverage of charging facilities for electric vehicles and bicycles, ensuring a reasonable distribution and effective management of charging order [1] Group 2: Parking Management - The plan includes measures to strengthen the management of motor vehicle parking and movement [1] - It proposes to increase parking facility supply in the central urban area by creating an additional 20,000 parking spaces [1] - The initiative also includes utilizing civil defense projects to add 5,000 new parking spaces and creating 10,000 paid shared parking spaces [1] - There is a push to convert idle and inefficient buildings and industrial parks into parking structures [1]

Core Viewpoint - Yunnan Baiyao (000538) announced that its shareholder Xinhua Dou (002264) Industrial Group has pledged part of its shares in the company, indicating a potential shift in shareholder dynamics and liquidity concerns [1] Group 1: Shareholding and Pledge Details - Xinhua Dou and its concerted parties hold a total of 449,624,311 shares in Yunnan Baiyao [1] - The number of shares pledged this time is 6.75 million, which accounts for 1.50% of the shares held by Xinhua Dou and its concerted parties, and 0.38% of Yunnan Baiyao's total share capital [1] - The cumulative number of pledged shares now stands at 80.25 million, representing 17.85% of the shares held by Xinhua Dou and its concerted parties, and 4.50% of Yunnan Baiyao's total share capital [1]

Core Viewpoint - The Chinese building materials industry is at a critical juncture for transformation and upgrading, with a focus on green materials and digitalization, as outlined in the "Building Materials Industry Stabilization and Growth Work Plan (2025-2026)" issued by six government departments [1][2]. Group 1: Industry Policy and Direction - The "Plan" aims to promote stable operation and structural optimization in the building materials industry, emphasizing digital transformation, green low-carbon upgrades, and the application of green materials [2]. - The plan addresses the need for improvement in green low-carbon and intelligent manufacturing levels within the industry, creating new growth opportunities for ceramic enterprises [2][3]. Group 2: Company Initiatives and Achievements - Marco Polo, as a leading enterprise in the domestic ceramic industry, has proactively implemented measures such as establishing national-level green factories and creating benchmarks for intelligent production [1][2]. - The company has adopted clean energy sources, such as natural gas, and has built rooftop photovoltaic power stations, aligning with the "Plan" to accelerate green low-carbon transformation [2][6]. Group 3: Technological Innovations and Sustainability - Marco Polo's production base in Jiangxi has integrated advanced technologies and clean energy, showcasing a model for intelligent manufacturing in the industry [3][4]. - The company has achieved significant milestones in resource conservation, including 100% recycling of industrial water and the use of advanced desulfurization technology to exceed national emission standards [7][8]. Group 4: Product Innovation and Market Positioning - The company has developed a range of innovative products that meet evolving consumer demands for personalized and artistic ceramic solutions, enhancing its competitive edge [9][10]. - Marco Polo's commitment to R&D is evident, with cumulative investments reaching 1.047 billion yuan from 2022 to the third quarter of 2025, resulting in numerous patents and industry-leading technologies [10][12]. Group 5: Cultural Integration and Brand Development - The establishment of the Dongguan Ceramic Museum has facilitated the integration of traditional Chinese culture with modern production techniques, enhancing brand value and consumer engagement [10][12]. - Marco Polo's cultural initiatives have led to the development of unique ceramic products that reflect artistic and cultural heritage, further solidifying its market position [10][12].

近日，由前赛诺菲全球研发负责人、免疫学家刘勇军教授创立的生物医药创新企业——拓胜医药 （Tosun Pharmaceutical）宣布完成4000万美元天使轮融资。本轮融资，齐济投资携手嘉道资本共同领 投，泓宁亨泰、贝达药业（300558）旗下基金、泰格基金、松江国投、合肥生命健康基金、肥西产业基 金等知名机构跟投。 募集资金将主要用于推进第三代抗体偶联药物（ADC）的研发，聚焦于多靶点布局、差异化载荷的创 新设计及肿瘤管线的开发。 ...

本次融资由CormorantAssetManagement与ColumbiaThreadneedleInvestments共同领投，包含其他新老投资 者如BalyasnyAssetManagementL.P.、Point72、SquadronCapitalManagement及CasdinCapital等。此外还包 括向公司董事会主席及首席执行官路杨控制的实体配售约5,500万美元股份。 在本次私募融资中，公司将以每股A类普通股2.1667美元（相当于每股美国存托凭证（ADS）6.50美 元）的价格，向投资者发行64,615,386股A类普通股（相当于21,538,462股ADS，每股ADS代表3股A类普 通股）。 近日，阿诺医药宣布已就一项上市公司私募股权融资（PIPE）签署证券购买协议，预计融资总额约为 1.40亿美元（未扣除配售代理及其他相关费用）。 ...

近日，微芯生物发布公告称，公司与NizhnyNovgorodChemicalPharmaceuticalPlant（Nizhpharm）签署了 关于西达本胺的许可及分销协议。根据协议，Nizhpharm将获得西达本胺在多个授权地区的研发、注册 和商业化的独家权利。Nizhpharm将自行负责产品在授权地区的研发、上市注册、二次包装、运输及商 业化销售工作。Nizhpharm将按照协议的约定价格从公司采购产品用于授权区域内的商业化销售。 公告提到，Nizhpharm集团是俄罗斯联邦领先的制药企业之一，拥有逾百年历史。协议生效后，公司将 收到总计1,000万元人民币的首付款、近期监管材料转移里程碑及总计1,000万元人民币的当地注册上市 里程碑。 ...

（先声药业公告） 根据该协议，公司将从AbbVie收取首付款，以及最高可达10.55亿美元的选择性权益及里程碑付款，双方还约定就净销 售额收取分级特许权使用费。此次付款的收到，标志着公司与AbbVie在推进SIM0500临床开发合作方面取得了积极进 展。 近日，先声药业发布公告称，近日公司收到来自AbbVie支付的4000万美元款项，这是与AbbVie就研究性新候选药物 SIM0500所签订的海外许可选择权协议下的里程碑付款。 ...